Cargando…
Impaired semen quality in trans women: prevalence and determinants
STUDY QUESTION: What is the semen quality in trans women at time of fertility preservation, prior to the start of gender-affirming hormone treatment? SUMMARY ANSWER: Before the start of gender-affirming hormone treatment, semen quality in trans women was already strongly decreased compared to the ge...
Autores principales: | de Nie, I, Meißner, A, Kostelijk, E H, Soufan, A T, Voorn-de Warem, I A C, den Heijer, M, Huirne, J, van Mello, N M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368399/ https://www.ncbi.nlm.nih.gov/pubmed/32613241 http://dx.doi.org/10.1093/humrep/deaa133 |
Ejemplares similares
-
Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study
por: de Nie, Iris, et al.
Publicado: (2021) -
Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023) -
Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women
por: de Nie, I, et al.
Publicado: (2021) -
Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment
por: de Nie, Iris, et al.
Publicado: (2020) -
Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)